Scilex Holding (SCLX) Other Accumulated Expenses (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Other Accumulated Expenses of $255000.0 for Q1 2026, down 99.85% year-over-year from $168.4 million in Q1 2025, and down 99.89% on a QoQ basis from $231.8 million in Q4 2025.

Scilex Holding (SCLX) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Other Accumulated Expenses for 7 consecutive years, with $255000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Accumulated Expenses fell 99.85% year-over-year to $255000.0; the TTM figure through Mar 2026 stood at $255000.0 (down 99.85% YoY), while the FY2025 annual figure was $231.8 million, changed N/A from the prior year.
  • Other Accumulated Expenses came in at $255000.0 for Q1 2026 at Scilex Holding, down from $231.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $231.8 million in Q4 2025, with the low at $255000.0 in Q1 2026.
  • Average Other Accumulated Expenses over 5 years is $93.4 million, with a median of $89.7 million recorded in 2023.
  • Across the five-year window, Other Accumulated Expenses soared 984.25% in 2024 and sank 99.85% in 2026, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $30.9 million in 2022, then surged by 190.22% to $89.7 million in 2023, then jumped by 58.06% to $141.7 million in 2024, then jumped by 63.54% to $231.8 million in 2025, then plunged by 99.89% to $255000.0 in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $255000.0, $231.8 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 255,000.00
Dec 31, 2025 231.76 Mn
Sep 30, 2025 5.74 Mn
Jun 30, 2025 192.94 Mn
Mar 31, 2025 168.43 Mn
Sep 30, 2024 141.71 Mn
Jun 30, 2024 125.06 Mn
Mar 31, 2024 104.09 Mn
Dec 31, 2023 89.66 Mn
Sep 30, 2023 65.80 Mn
Jun 30, 2023 47.78 Mn
Mar 31, 2023 9.60 Mn
Dec 31, 2022 30.89 Mn
Dec 31, 2021 7.36 Mn
Dec 31, 2020 25,760.00